Cargando…

Microbiota and Lung Cancer. Opportunities and Challenges for Improving Immunotherapy Efficacy

The advances in molecular biology and the emergence of Next Generation Sequencing (NGS) have revealed that microbiome composition is closely related with health and disease, including cancer. This relationship affects different levels of cancer such as development, progression, and response to treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ocáriz-Díez, Maitane, Cruellas, Mara, Gascón, Marta, Lastra, Rodrigo, Martínez-Lostao, Luis, Ramírez-Labrada, Ariel, Paño, José Ramón, Sesma, Andrea, Torres, Irene, Yubero, Alfonso, Pardo, Julián, Isla, Dolores, Gálvez, Eva M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552963/ https://www.ncbi.nlm.nih.gov/pubmed/33117698 http://dx.doi.org/10.3389/fonc.2020.568939

Ejemplares similares

From Tumor Mutational Burden to Blood T Cell Receptor: Looking for the Best Predictive Biomarker in Lung Cancer Treated with Immunotherapy
por: Sesma, Andrea, et al.
Publicado: (2020)

Intratumoral versus Circulating Lymphoid Cells as Predictive Biomarkers in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Is the Easiest Path the Best One?
por: Gascón, Marta, et al.
Publicado: (2020)

A Subset of PD-1-Expressing CD56(bright) NK Cells Identifies Patients with Good Response to Immune Checkpoint Inhibitors in Lung Cancer
por: Gascón-Ruiz, Marta, et al.
Publicado: (2023)

PD-1 is expressed in cytotoxic granules of NK cells and rapidly mobilized to the cell membrane following recognition of tumor cells
por: Pesini, Cecilia, et al.
Publicado: (2022)

The Multifaceted Function of Granzymes in Sepsis: Some Facts and a Lot to Discover
por: Garzón-Tituaña, Marcela, et al.
Publicado: (2020)

Integrated analysis of circulating immune cellular and soluble mediators reveals specific COVID19 signatures at hospital admission with utility for prediction of clinical outcomes
por: Uranga-Murillo, Iratxe, et al.
Publicado: (2022)

Integration of In Silico and In Vitro Analysis of Gliotoxin Production Reveals a Narrow Range of Producing Fungal Species
por: Redrado, Sergio, et al.
Publicado: (2022)

Granzyme A inhibition reduces inflammation and increases survival during abdominal sepsis
por: Garzón-Tituaña, Marcela, et al.
Publicado: (2021)

Application of pharmacokinetic/pharmacodynamic analysis to evaluate the adequacy of antimicrobial therapy for pediatric acute otitis media in Spain before and after the introduction of the PCV7 vaccine
por: Ibar-Bariain, Maitane, et al.
Publicado: (2019)

Recalling the Biological Significance of Immune Checkpoints on NK Cells: A Chance to Overcome LAG3, PD1, and CTLA4 Inhibitory Pathways by Adoptive NK Cell Transfer?
por: Lanuza, Pilar M., et al.
Publicado: (2020)

Diagnosis of Malnutrition According to GLIM Criteria Predicts Complications and 6-Month Survival in Cancer Outpatients
por: Gascón-Ruiz, Marta, et al.
Publicado: (2022)

Determination of the Concentration of IgG against the Spike Receptor-Binding Domain That Predicts the Viral Neutralizing Activity of Convalescent Plasma and Serum against SARS-CoV-2
por: Santiago, Llipsy, et al.
Publicado: (2021)

Biological relevance of Granzymes A and K during E. coli sepsis
por: Uranga-Murillo, Iratxe, et al.
Publicado: (2021)

All About (NK Cell-Mediated) Death in Two Acts and an Unexpected Encore: Initiation, Execution and Activation of Adaptive Immunity
por: Ramírez-Labrada, Ariel, et al.
Publicado: (2022)

Pediatric Cancer Immunotherapy: Opportunities and Challenges
por: Wedekind, Mary Frances, et al.
Publicado: (2018)

New opportunities for nanoparticles in cancer immunotherapy
por: Park, Wooram, et al.
Publicado: (2018)

Challenges and Opportunities for Effective Cancer Immunotherapies
por: Slaney, Clare Y., et al.
Publicado: (2020)

Golden Age of Immunotherapy: Challenges and Opportunities
por: Chung, Yeonseok, et al.
Publicado: (2022)

Modeling Natural Killer Cell Targeted Immunotherapies
por: Lopez-Lastra, Silvia, et al.
Publicado: (2017)

Current status and future perspectives of immunotherapy in Latin America and Cuba
por: Diaz Rodriguez, Alexander, et al.
Publicado: (2014)

Ovarian cancer immunotherapy: opportunities, progresses and challenges
por: Liu, Bei, et al.
Publicado: (2010)

Clinical opportunities in combining immunotherapy with radiation therapy
por: Finkelstein, Steven E., et al.
Publicado: (2012)

T-Cell-Based Immunotherapy for Osteosarcoma: Challenges and Opportunities
por: Wang, Zhan, et al.
Publicado: (2016)

Opportunities for immunotherapy in microsatellite instable colorectal cancer
por: Westdorp, Harm, et al.
Publicado: (2016)

Cancer nanomedicine meets immunotherapy: opportunities and challenges
por: Sun, Qingxue, et al.
Publicado: (2020)

Immunotherapy for sarcomas: new frontiers and unveiled opportunities
por: Birdi, Harsimrat Kaur, et al.
Publicado: (2021)

Opportunities for CAR-T Cell Immunotherapy in HIV Cure
por: Campos-Gonzalez, Gerard, et al.
Publicado: (2023)

T cell immunotherapy for cervical cancer: challenges and opportunities
por: Yu, Lingfeng, et al.
Publicado: (2023)

Immunotherapies targeting tumor vasculature: challenges and opportunities
por: Dianat-Moghadam, Hassan, et al.
Publicado: (2023)

204 IGE/IGG4 Ratio as a Possible Surrogate Marker of Clinical Efficacy During Allergen-Specific Immunotherapy with House Dust Mite Vaccines
por: Labrada, Alexis, et al.
Publicado: (2012)

487 Safety of Sublingual Immunotherapy with Standardized Vaccines of Domestic Mites
por: Alvarez, Mirta, et al.
Publicado: (2012)

Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy Era
por: Saba, Nabil F., et al.
Publicado: (2022)

Safety of sublingual immunotherapy for asthma with standardized house dust mite vaccines in a tropical setting: Results of a nation-wide pharmacovigilance study
por: Morejón, Maytee Mateo, et al.
Publicado: (2015)

Immunotherapy of hepatocellular carcinoma: Unique challenges and clinical opportunities
por: Pardee, Angela D., et al.
Publicado: (2012)

Immunotherapy and pancreatic cancer: unique challenges and potential opportunities
por: Young, Kate, et al.
Publicado: (2018)

DNA Repair Deficiency in Breast Cancer: Opportunities for Immunotherapy
por: Gilmore, Elaine, et al.
Publicado: (2019)

The Metabolic Features of Tumor-Associated Macrophages: Opportunities for Immunotherapy?
por: Mojsilovic, Sonja S., et al.
Publicado: (2021)

Immune Profiling of Medullary Thyroid Cancer—An Opportunity for Immunotherapy
por: Hińcza-Nowak, Kinga, et al.
Publicado: (2021)

Liquid Biopsy in Hepatocellular Carcinoma: Opportunities and Challenges for Immunotherapy
por: Maravelia, Panagiota, et al.
Publicado: (2021)

Correction: Immunotherapy for sarcomas: new frontiers and unveiled opportunities
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m10rilkjmrhbgpi27kkaru5l93